Recent news on Follitropin Beta

Azko's Organon sales climb 8%, IPO in next few weeks  -  Feb 15, 2007
Pharma Times (subscription),The infertility treatment Puregon/Follistim (follitropin beta) - Organon's number one product - achieved a record result, rising 8% to 384 million euros,

Akzo Nobel planning IPO for pharma business  Feb 7, 2006
The increase was attributed to strong performances from fertility treatment Puregon/Follistim (follitropin beta) and contraceptive Nuvaring (etonogestrel ... - Pharma Times (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional